FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1880966051> ?p ?o ?g. }

• W1880966051 endingPage "690" @default.
• W1880966051 startingPage "684" @default.
• W1880966051 abstract "Effective artificial oxygen carriers may offer a solution to tackling current transfusion medicine challenges such as blood shortages, red blood cell storage lesions, and transmission of emerging pathogens. These products, could provide additional therapeutic benefits besides oxygen delivery for an array of medical conditions. To meet these needs, we developed a hemoglobin (Hb)-based oxygen carrier, HemoTech, which utilizes the concept of pharmacologic cross-linking. It consists of purified bovine Hb cross-linked intramolecularly with open ring adenosine-5′-triphosphate (ATP) and intermolecularly with open ring adenosine, and conjugated with reduced glutathione (GSH). In this composition, ATP prevents Hb dimerization, and adenosine promotes formation of Hb polymers as well as counteracts the vasoconstrictive and pro-inflammatory properties of Hb via stimulation of adenosine receptors. ATP also serves as a regulator of vascular tone through activation of purinergic receptors. GSH blocks Hb's extravasation and glomerular filtration by lowering the isoelectric point, as well as shields heme from nitric oxide and reactive oxygen species. HemoTech and its manufacturing technology have been broadly tested, including viral and prion clearance validation studies and various nonclinical pharmacology, toxicology, genotoxicity, and efficacy tests. The clinical proof-of-concept was carried out in sickle cell anemia subjects. The preclinical and clinical studies indicate that HemoTech works as a physiologic oxygen carrier and has efficacy in treating: (i) acute blood loss anemia by providing a temporary oxygen bridge while stimulating an endogenous erythropoietic response; (ii) sickle cell disease by counteracting vaso-occlusive/inflammatory episodes and anemia; and (iii) ischemic vascular diseases particularly thrombotic and restenotic events. The pharmacologic cross-linking of Hb with ATP, adenosine, and GSH showed usefulness in designing an artificial oxygen carrier for multiple therapeutic indications." @default.
• W1880966051 created "2016-06-24" @default.
• W1880966051 creator A5008304227 @default.
• W1880966051 creator A5019639910 @default.
• W1880966051 creator A5019935894 @default.
• W1880966051 creator A5073446340 @default.
• W1880966051 creator A5088927046 @default.
• W1880966051 date "2014-07-01" @default.
• W1880966051 modified "2023-09-25" @default.
• W1880966051 title "Artificial Oxygen Carrier With Pharmacologic Actions of Adenosine-5′-Triphosphate, Adenosine, and Reduced Glutathione Formulated to Treat an Array of Medical Conditions" @default.
• W1880966051 cites W1502198446 @default.
• W1880966051 cites W1569206730 @default.
• W1880966051 cites W1582167355 @default.
• W1880966051 cites W1898221764 @default.
• W1880966051 cites W1972059326 @default.
• W1880966051 cites W1973776869 @default.
• W1880966051 cites W2002129013 @default.
• W1880966051 cites W2004723675 @default.
• W1880966051 cites W2006061079 @default.
• W1880966051 cites W2028482736 @default.
• W1880966051 cites W2029875961 @default.
• W1880966051 cites W2040350871 @default.
• W1880966051 cites W2042299156 @default.
• W1880966051 cites W2043968509 @default.
• W1880966051 cites W2045172594 @default.
• W1880966051 cites W2046084024 @default.
• W1880966051 cites W2046384678 @default.
• W1880966051 cites W2051382343 @default.
• W1880966051 cites W2066056445 @default.
• W1880966051 cites W2076186872 @default.
• W1880966051 cites W2090360877 @default.
• W1880966051 cites W2103331878 @default.
• W1880966051 cites W2138617493 @default.
• W1880966051 cites W2147582219 @default.
• W1880966051 cites W2151470584 @default.
• W1880966051 cites W2411323646 @default.
• W1880966051 cites W4246943568 @default.
• W1880966051 doi "https://doi.org/10.1111/aor.12337" @default.
• W1880966051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24980041" @default.
• W1880966051 hasPublicationYear "2014" @default.
• W1880966051 type Work @default.
• W1880966051 sameAs 1880966051 @default.
• W1880966051 citedByCount "20" @default.
• W1880966051 countsByYear W18809660512014 @default.
• W1880966051 countsByYear W18809660512015 @default.
• W1880966051 countsByYear W18809660512016 @default.
• W1880966051 countsByYear W18809660512017 @default.
• W1880966051 countsByYear W18809660512018 @default.
• W1880966051 countsByYear W18809660512019 @default.
• W1880966051 countsByYear W18809660512020 @default.
• W1880966051 countsByYear W18809660512021 @default.
• W1880966051 countsByYear W18809660512022 @default.
• W1880966051 countsByYear W18809660512023 @default.
• W1880966051 crossrefType "journal-article" @default.
• W1880966051 hasAuthorship W1880966051A5008304227 @default.
• W1880966051 hasAuthorship W1880966051A5019639910 @default.
• W1880966051 hasAuthorship W1880966051A5019935894 @default.
• W1880966051 hasAuthorship W1880966051A5073446340 @default.
• W1880966051 hasAuthorship W1880966051A5088927046 @default.
• W1880966051 hasConcept C178790620 @default.
• W1880966051 hasConcept C181199279 @default.
• W1880966051 hasConcept C185592680 @default.
• W1880966051 hasConcept C203014093 @default.
• W1880966051 hasConcept C2776991684 @default.
• W1880966051 hasConcept C2779564974 @default.
• W1880966051 hasConcept C2993864201 @default.
• W1880966051 hasConcept C48349386 @default.
• W1880966051 hasConcept C538909803 @default.
• W1880966051 hasConcept C540031477 @default.
• W1880966051 hasConcept C55493867 @default.
• W1880966051 hasConcept C71924100 @default.
• W1880966051 hasConcept C98274493 @default.
• W1880966051 hasConceptScore W1880966051C178790620 @default.
• W1880966051 hasConceptScore W1880966051C181199279 @default.
• W1880966051 hasConceptScore W1880966051C185592680 @default.
• W1880966051 hasConceptScore W1880966051C203014093 @default.
• W1880966051 hasConceptScore W1880966051C2776991684 @default.
• W1880966051 hasConceptScore W1880966051C2779564974 @default.
• W1880966051 hasConceptScore W1880966051C2993864201 @default.
• W1880966051 hasConceptScore W1880966051C48349386 @default.
• W1880966051 hasConceptScore W1880966051C538909803 @default.
• W1880966051 hasConceptScore W1880966051C540031477 @default.
• W1880966051 hasConceptScore W1880966051C55493867 @default.
• W1880966051 hasConceptScore W1880966051C71924100 @default.
• W1880966051 hasConceptScore W1880966051C98274493 @default.
• W1880966051 hasIssue "8" @default.
• W1880966051 hasLocation W18809660511 @default.
• W1880966051 hasLocation W18809660512 @default.
• W1880966051 hasOpenAccess W1880966051 @default.
• W1880966051 hasPrimaryLocation W18809660511 @default.
• W1880966051 hasRelatedWork W1520558152 @default.
• W1880966051 hasRelatedWork W1880966051 @default.
• W1880966051 hasRelatedWork W1977213671 @default.
• W1880966051 hasRelatedWork W2016479012 @default.
• W1880966051 hasRelatedWork W2046460580 @default.
• W1880966051 hasRelatedWork W2119913374 @default.
• W1880966051 hasRelatedWork W2160775206 @default.
• W1880966051 hasRelatedWork W2748952813 @default.

• next